1. FDA drug label Xanax (alprazolam tablets) Revised 2016 [cited 2022 May 24]
2. Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005 May;18(3):249-55. doi: 10.1097/01.yco.0000165594.60434.84. PMID:16639148. [cited 2022 May 24]
3. Connecticut Gvt. Department of Consumer Protection Information “Aprazolam” [cited 2022 May 24]
4. FDA information, “Finding and Learning About Side Effects (adverse reactions).” 2018 July 19 [cited 2022 May 24]
5. DailyMed prescription drug information, “Alprazolam” [online] Mar 21, 2021 [cited 2022 May 24]
6. Ashton H, “Benzodiazepines – How they Work and How to Withdraw” aka “The Ashton Manual” revised Aug 2002 [online] [cited 2022 May 24]
7. Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet. 1989 Jun;16(6):337-64. doi: 10.2165/00003088-198916060-00002. PMID: 2567646. [cited 2022 May 24]
8. Browne JL, Hauge KJ. A review of alprazolam withdrawal. Drug Intell Clin Pharm. 1986 Nov;20(11):837-41. doi: 10.1177/106002808602001102. PMID: 3536383. [cited 2022 May 24]
9. Bosshart H. Withdrawal-induced delirium associated with a benzodiazepine switch: a case report. J Med Case Rep. 2011 May 26;5:207. doi: 10.1186/1752-1947-5-207. PMID: 21615891; PMCID: PMC3117827. [cited 2022 May 24]
10. Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez-Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med. 1986 Oct 2;315(14):854-9. doi: 10.1056/NEJM198610023151403. PMID: 3092053. [cited 2022 May 24]
11. O’brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66 Suppl 2:28-33. PMID: 15762817. [cited 2022 May 24]
12. Kang M, Galuska MA, Ghassemzadeh S. Benzodiazepine Toxicity. [Updated 2021 Jul 1]. In: StatPearls Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482238/ [cited 2022 May 24]
13. Ananth J. Benzodiazepines: selective use to avoid addiction. Postgrad Med. 1982 Oct;72(4):271-6. doi: 10.1080/00325481.1982.11716231. PMID: 6126869. [cited 2022 May 24]
14. Schmitz A. Benzodiazepine use, misuse, and abuse: A review. Ment Health Clin. 2016;6(3):120-126. Published 2016 May 6. doi:10.9740/mhc.2016.05.120 [cited 2022 May 24]
15. Temte V, Kjeldstadli K, Bruun LD, Birdal M, Bachs L, Karinen R, Middelkoop G, Øiestad E, Høiseth G. An Experimental Study of Diazepam and Alprazolam Kinetics in Urine and Oral Fluid Following Single Oral Doses. J Anal Toxicol. 2019 Mar 1;43(2):104-111. doi: 10.1093/jat/bky062. PMID: 30517712. [cited 2022 May 24]
16. Santo L, Rui P, Ashman J, “Physician Office Visits at which Benzodiazepines were Prescribed: Findings from 2014-2016 National Ambulatory Medical Care Survey” CDC national Health Statistics Reports #137 January 17,2020 [cited 2022 May 24]
17. Otte C. Cognitive behavioral therapy in anxiety disorders: current state of the evidence. Dialogues Clin Neurosci. 2011;13(4):413-421. doi:10.31887/DCNS.2011.13.4/cotte [cited 2022 May 24]
18. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci. 2008;9(10):788-796. doi:10.1038/nrn2345 [cited 2022 May 24]
19. Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug;48(8):720-7. doi: 10.1016/j.brat.2010.04.002. Epub 2010 Apr 28. PMID: 20546699; PMCID: PMC5962448. [cited 2022 May 24]
20. He Q, Chen X, Wu T, Li L, Fei X. Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies. J Clin Neurol. 2019;15(1):9-19. doi:10.3988/jcn.2019.15.1.9 [cited 2022 May 24]
21. Statistical Report “The Top 300 of 2021” published online by clincalc database [cited 2022 May 24]
22. CDC statistics report published August 2021, Fatal and Nonfatal Overdoses Benzodiazepines [cited 2023 Jan 24]
23. Genuis SJ. Toxic causes of mental illness are overlooked. Neurotoxicology. 2008 Nov;29(6):1147-9. doi: 10.1016/j.neuro.2008.06.005. Epub 2008 Jun 24. PMID: 18621076. [cited 2022 May 24]
24. Swedish Council on Health Technology Assessment. Treatment of Anxiety Disorders: A Systematic Review Stockholm: Swedish Council on Health Technology Assessment (SBU); 2005 Nov. SBU Yellow Report No. 171/1+2. PMID: 28876726. [cited 2022 May 24]
25. Ait-Daoud N, Hamby AS, Sharma S, Blevins D. A Review of Alprazolam Use, Misuse, and Withdrawal. J A Med. 2018;12(1):4-10. doi:10.1097/ADM.0000000000000350 [cited 2022 May 24]
26. Pecknold JC, Swinson RP, Kuch K, Lewis CP. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. Arch Gen Psychiatry. 1988 May;45(5):429-36. doi: 10.1001/archpsyc.1988.01800290043006. PMID: 3282479. [cited 2022 May 24]
27. Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF. Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry. 1987 Mar;144(3):303-8. doi: 10.1176/ajp.144.3.303. PMID: 3826428. [cited 2022 May 24]
28. Laegreid L, Olegård R, Walström J, Conradi N. Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr. 1989 Jan;114(1):126-31. doi: 10.1016/s0022-3476(89)80619-5. PMID: 2562851.[cited 2022 May 24]
29. Risse SC, Whitters A, Burke J, Chen S, Scurfield RM, Raskind MA. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. J Clin Psychiatry. 1990 May;51(5):206-9. PMID: 2335496. [cited 2022 Oct 21]
30. Pétursson H. The benzodiazepine withdrawal syndrome. Add. 1994 Nov;89(11):1455-9. doi: 10.1111/j.1360-0443.1994.tb03743.x. PMID: 7841856. [cited 2022 Oct 21]
31. Goffinet S. Mécanisme d’action, indications et abus des benzodiazépines anxiolytiques [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs]. Ann Med Psychol (Paris). 1993 Jan;151(1):47-63. French. PMID: 7905724. [cited 2023 Jan 24]
32. Lader M. Long-term anxiolytic therapy: the issue of drug withdrawal. J Clin Psychiatry. 1987 Dec;48 Suppl:12-6. PMID: 2891684. [cited 2023 Jan 24]
33. Peart R, Toxicity, Cognitive Impairment, Long Term Damage, and The Post Withdrawal Syndrome [published online December 2000] [cited 2023 Jan 24]
34. Perlis RH. Misdiagnosis of bipolar disorder. Am J Manag Care. 2005 Oct;11(9 Suppl):S271-4. PMID: 16232009. [cited 2023 Jan 24]
35. Boyadzhieva A, Kayhan E. Keeping the Breath in Mind: Respiration, Neural Oscillations, and the Free Energy Principle. Front Neurosci. 2021 Jun 29;15:647579. doi: 10.3389/fnins.2021.647579. PMID: 34267621; PMCID: PMC8275985. [cited 2023 Jan 24]
36. Saeed SA, Cunningham K, Bloch RM. Depression and Anxiety Disorders: Benefits of Exercise, Yoga, and Meditation. Am Fam Physician. 2019 May 15;99(10):620-627. PMID: 31083878. [cited 2023 Jan 24]